In vivo cyclic overexpression of Yamanaka factors restricted to neurons reverses age-associated phenotypes and enhances memory performance.
Alejandro Antón-FernándezMarta Roldán-LázaroLaura Vallés-SaizJesús AvilaFélix HernándezPublished in: Communications biology (2024)
In recent years, there has been success in partially reprogramming peripheral organ cells using cyclic Yamanaka transcription factor (YF) expression, resulting in the reversal of age-related pathologies. In the case of the brain, the effects of partial reprogramming are scarcely known, and only some of its effects have been observed through the widespread expression of YF. This study is the first to exclusively partially reprogram a specific subpopulation of neurons in the cerebral cortex of aged mice. The in vivo model demonstrate that YF expression in postmitotic neurons does not dedifferentiate them, and it avoids deleterious effects observed with YF expression in other cell types. Additionally, our study demonstrates that only cyclic, not continuous, expression of YF result in a noteworthy enhancement of cognitive function in adult mice. This enhancement is closely tied to increased neuronal activation in regions related to memory processes, reversed aging-related epigenetic markers and to increased plasticity, induced by the reorganization of the extracellular matrix. These findings support the therapeutic potential of targeted partial reprogramming of neurons in addressing age-associated phenotypes and neurodegenerative diseases correlated with aging.
Keyphrases
- poor prognosis
- transcription factor
- extracellular matrix
- spinal cord
- binding protein
- type diabetes
- dna methylation
- long non coding rna
- gene expression
- stem cells
- multiple sclerosis
- adipose tissue
- subarachnoid hemorrhage
- working memory
- oxidative stress
- functional connectivity
- metabolic syndrome
- cerebral ischemia
- skeletal muscle
- mesenchymal stem cells
- young adults
- single cell
- spinal cord injury
- insulin resistance
- dna binding
- childhood cancer